Andere talen Clinuvel Pharmaceuticals Limited

Aandelen

CUV

AU000000CUV3

Beurs gesloten - Australian S.E. Andere beurzen 08:10:45 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
14,57 ^AUD	-2,80%		+1,32%	-8,94%

14/03	Clinuvel Pharmaceuticals lanceert aandeleninkoopprogramma	MT
14/03	CLINUVEL PHARMACEUTICALS LIMITED : Morgans Financial past advies aan	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors	28/03
Clinuvel Pharmaceuticals Launches Share Buyback Program	14/03
Clinuvel Pharmaceuticals Limited announces an Equity Buyback for 1,500,000 shares, representing 2.99% of its issued share capital.	14/03
Clinuvel Pharmaceuticals Limited authorizes a Buyback Plan.	14/03
Biotech-Unternehmen CLINUVEL launcht Photomedizin-Stiftung bei Event von Lady Gaga	07/03
Malibu shines a light on CLINUVEL’s pioneering work in photomedicine	05/03
Clinuvel Reports Positive Results in SCENESSE Study	04/03
Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023	21/02
Clinuvel Pharmaceuticals Limited Announces Change to Registered Office	07/12
Clinuvel Doses First Patient in Phase 3 Trial of Vitiligo Treatment	18-10-23
Clinuvel Pharmaceuticals Limited Announces Board Changes	29-09-23
Clinuvel Pharmaceuticals Teams Up With Vitiligo Experts to Assess Scenesse	13-09-23
Clinuvel Pharmaceuticals Limited Announces Dividend for the Full Year Ended June 30, 2023, Payable on September 20, 2023	29-08-23
Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2023	29-08-23
Clinuvel Pharmaceuticals Secures Supply Contract for Porphyria Medication with the US Department of Veterans Affairs	26-07-23
Clinuvel Pharmaceuticals Secures Patents for Melanocortins for Treatment of Central Nervous System Disorders	14-07-23
Clinuvel Pharmaceuticals Treats First Patient in Phase Two Stroke Trial	20-03-23
Clinuvel Pharmaceuticals Limited Announces Technical Note - CUV803 Study and AIS	20-03-23
Clinuvel Pharmaceuticals Limited Announces First Stroke Patient Treated with PRENUMBRA Instant	19-03-23
Clinuvel Pharmaceuticals Limited Present DNA Repair Data At American Academy of Dermatology Meeting	16-03-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Clinuvel Pharmaceuticals Limited

Aandelen

CUV

AU000000CUV3

Andere talen

Filters